Clinical Development, Regulatory, and Reimbursement Review Duration of New Drugs in the US and European Countries
- DOI
- 10.1001/jamahealthforum.2026.2332
- Published
- 2026-07-24
- Container
- JAMA Health Forum
- Publisher
- American Medical Association (AMA)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1001/jamahealthforum.2026.2332,
title = {Clinical Development, Regulatory, and Reimbursement Review Duration of New Drugs in the US and European Countries},
author = {Simon Hediger and Camille E.G. Glaus and Stacie B. Dusetzina and Ulrich-Peter Rohr and Thomas J. Hwang and Kerstin Noelle Vokinger},
year = {2026},
journal = {JAMA Health Forum},
doi = {10.1001/jamahealthforum.2026.2332},
url = {https://doi.org/10.1001/jamahealthforum.2026.2332}
}RIS
TY - JOUR TI - Clinical Development, Regulatory, and Reimbursement Review Duration of New Drugs in the US and European Countries AU - Simon Hediger AU - Camille E.G. Glaus AU - Stacie B. Dusetzina AU - Ulrich-Peter Rohr AU - Thomas J. Hwang AU - Kerstin Noelle Vokinger PY - 2026 JO - JAMA Health Forum DO - 10.1001/jamahealthforum.2026.2332 UR - https://doi.org/10.1001/jamahealthforum.2026.2332 ER -
APA
Hediger, S., Glaus, C. E., Dusetzina, S. B., Rohr, U., Hwang, T. J., & Vokinger, K. N. (2026). Clinical Development, Regulatory, and Reimbursement Review Duration of New Drugs in the US and European Countries. JAMA Health Forum. https://doi.org/10.1001/jamahealthforum.2026.2332
Source records
- crossref · retrieved 2026-09-26T15:01:19.282Z